CSB

Stanford School of Medicine

Chemical & Systems Biology

 
 

A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing’s Tumours.

Posted by CSB Department on January 1, 2003

Meyer T, McTiernan A, Whelan J. (2003) Sarcoma 7(1):13-7 [PubMed]